NCT04403620View on ClinicalTrials.gov

HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
RADIATION

Intensity-modulated Radiation Therapy (IMRT)

Patients will receive adjuvant radiation therapy using intensity-modulated radiation therapy (IMRT) within 8 weeks of surgical resection

Trial Locations (1)

75390

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER